Berkan Kurt, MD (@berkankurt.bsky.social)

Excited to share our new paper is now out in #Atherosclerosis: In patients with #ASCVD, adding #bioADM to the ESC-recommended #SMART risk score improves risk prediction and model performance. Thanks to all collaborators for the joint effort. Read here (open access): tinyurl.com/3jtdhpzv

loading . . .

Adjustment of the SMART risk score by bioactive adrenomedullin enables a more accurate prediction of mortality in patients with ASCVD Bioactive adrenomedullin 1-52 (bio-ADM) is a novel biomarker for the assessment of endothelial function and prediction of adverse outcomes in patients with acute heart failure and cardiogenic shock. T... https://tinyurl.com/3jtdhpzv